Skip to content

Clinical trials

Phase 1/2 Parkinson Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 1/2 Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20052
20062
20071
20084
20098
20102
20115
20124
20132
20141
20154
20161
20176
20189
20194
20204
20212
20227
20236
20245
202510
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Recruiting13
Unknown status13
Terminated8
Active, not recruiting6
Not yet recruiting5
Withdrawn5
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)3
Apeiron Research Center2
Herantis Pharma Plc.2
Integrative Research Laboratories AB2
MeiraGTx, LLC2
Newron Sweden AB2
Prabesh Kanel2
Radboud University Medical Center2
Shanghai Vitalgen BioPharma Co., Ltd.2
State University of New York at Buffalo2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease102
Movement Disorders7
Neurodegenerative Diseases6
Brain Diseases5
Alzheimer Disease4
Dyskinesias4
Nervous System Diseases3
Parkinsonian Disorders3
Amyotrophic Lateral Sclerosis2
Basal Ganglia Diseases2

Trials

Showing 51 to 75 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.